Cargando…

Addressing the threat of drug-resistant tuberculosis : a realistic assessment of the challenge : workshop summary /

"Tuberculosis is one of the leading causes of death in the world today, with 4,500 people dying from the disease every day. Many cases of TB can be cured by available antibiotics, but some TB is resistant to multiple drugs--a major and growing threat worldwide. The Institute of Medicine's...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation
Otros Autores: Giffin, Robert B., Robinson, Sally
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press, 2009.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 EBOOKCENTRAL_ocn609649571
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cnu---unuuu
008 100427s2009 dcuab ob 100 0 eng d
010 |a  2011420444 
040 |a N$T  |b eng  |e pn  |c N$T  |d IDEBK  |d COF  |d OCLCQ  |d E7B  |d CU3  |d OCLCQ  |d ORU  |d CDX  |d OCLCQ  |d YDXCP  |d OCLCA  |d OCLCF  |d OCLCQ  |d NLGGC  |d MMU  |d KIJ  |d OCLCO  |d OCL  |d OCLCO  |d OCLCQ  |d OCLCO  |d EBLCP  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d LOA  |d OCLCO  |d AZK  |d OCLCO  |d OCLCA  |d VT2  |d OCLCQ  |d OCLCO  |d OCLCO  |d TOA  |d OCLCO  |d MOR  |d PIFAG  |d OCLCO  |d OCLCQ  |d ZCU  |d OCLCO  |d OCLCQ  |d MERUC  |d OCLCQ  |d OCLCO  |d OCLCA  |d U3W  |d OCLCA  |d BUF  |d OCLCO  |d MERER  |d CUY  |d STF  |d WRM  |d VNS  |d OCLCO  |d VTS  |d OCLCO  |d COCUF  |d AGLDB  |d OCLCQ  |d ICG  |d NRAMU  |d EZ9  |d AU@  |d OCLCO  |d OCLCQ  |d OCLCO  |d WYU  |d OCLCO  |d S9I  |d OCLCQ  |d DKC  |d OCLCQ  |d OCLCO  |d M8D  |d OCLCO  |d UX1  |d OCL  |d OCLCO  |d OCLCQ  |d UKAHL  |d OCLCQ  |d OCLCA  |d OCLCQ  |d OCL  |d OCLCA  |d INARC  |d UKCRE  |d AJS  |d TUHNV  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCL 
016 7 |a 101525250  |2 DNLM 
019 |a 495719849  |a 665195604  |a 764531736  |a 923280829  |a 960207601  |a 961550173  |a 962562995  |a 971069969  |a 988408554  |a 991953759  |a 1021265509  |a 1028764689  |a 1037938426  |a 1038616976  |a 1045537221  |a 1064111008  |a 1081274247  |a 1119503615  |a 1119507480  |a 1153469794  |a 1156343327  |a 1204384765  |a 1204385818  |a 1228559653  |a 1243598407 
020 |a 9780309130455  |q (electronic bk.) 
020 |a 030913045X  |q (electronic bk.) 
020 |z 0309130441  |q (pbk.) 
020 |z 9780309130448  |q (pbk.) 
024 8 |a 9786612454844 
029 1 |a AU@  |b 000051313867 
029 1 |a DEBBG  |b BV043117542 
029 1 |a DEBBG  |b BV044109012 
029 1 |a DEBSZ  |b 421901578 
029 1 |a NZ1  |b 13863059 
029 1 |a AU@  |b 000047746897 
035 |a (OCoLC)609649571  |z (OCoLC)495719849  |z (OCoLC)665195604  |z (OCoLC)764531736  |z (OCoLC)923280829  |z (OCoLC)960207601  |z (OCoLC)961550173  |z (OCoLC)962562995  |z (OCoLC)971069969  |z (OCoLC)988408554  |z (OCoLC)991953759  |z (OCoLC)1021265509  |z (OCoLC)1028764689  |z (OCoLC)1037938426  |z (OCoLC)1038616976  |z (OCoLC)1045537221  |z (OCoLC)1064111008  |z (OCoLC)1081274247  |z (OCoLC)1119503615  |z (OCoLC)1119507480  |z (OCoLC)1153469794  |z (OCoLC)1156343327  |z (OCoLC)1204384765  |z (OCoLC)1204385818  |z (OCoLC)1228559653  |z (OCoLC)1243598407 
037 |a 245484  |b MIL 
050 4 |a RC311.1  |b .A33 2009eb 
060 4 |a 2010 B-774 
060 4 |a WF 200  |b A2275 2009 
072 7 |a MED  |x 062000  |2 bisacsh 
082 0 4 |a 616.9/95  |2 22 
049 |a UAMI 
245 0 0 |a Addressing the threat of drug-resistant tuberculosis :  |b a realistic assessment of the challenge : workshop summary /  |c Robert Giffin and Sally Robinson, rapporteurs ; Institute of Medicine of the National Academies. 
260 |a Washington, D.C. :  |b National Academies Press,  |c 2009. 
300 |a 1 online resource (xvi, 235 pages) :  |b illustrations (some color), maps (some color) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file  |2 rda 
504 |a Includes bibliographical references. 
505 0 |a Introduction -- The global spread of multidrug-resistant and extensively drug-resistant tuberculosis -- MDR TB transmission, HIV coinfection, and transmission control -- Diagnosis -- Infrastructure and health care delivery systems -- Global systems for the purchase and delivery of TB drugs -- Research on the global control of TB: understanding the role of drugs, vaccines, and funding -- Strategies for confronting the global MDR and XDR TB crisis. 
520 |a "Tuberculosis is one of the leading causes of death in the world today, with 4,500 people dying from the disease every day. Many cases of TB can be cured by available antibiotics, but some TB is resistant to multiple drugs--a major and growing threat worldwide. The Institute of Medicine's Forum on Drug Discovery, Development, and Translation hosted a workshop on November 5, 2008, to address the mounting concern of drug-resistant TB. The session brought together a wide range of international experts to discuss what is known and not known about this growing threat, and to explore possible solutions."--Publisher's website. 
588 0 |a Print version record. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Multidrug-resistant tuberculosis  |v Congresses. 
650 0 |a Tuberculosis  |v Congresses. 
650 0 |a Drug resistance  |v Congresses. 
650 0 |a Antitubercular agents  |v Congresses. 
650 0 |a Multidrug-resistant tuberculosis. 
650 0 |a Antitubercular agents. 
650 1 2 |a Tuberculosis, Multidrug-Resistant 
650 1 2 |a Tuberculosis, Multidrug-Resistant  |x prevention & control 
650 1 2 |a Extensively Drug-Resistant Tuberculosis  |x prevention & control 
650 2 2 |a HIV Infections  |x complications 
650 2 2 |a Internationality 
650 2 2 |a Tuberculosis, Multidrug-Resistant  |x transmission 
650 2 2 |a Antitubercular Agents 
650 2 2 |a Drug Resistance, Multiple, Bacterial  |x prevention & control 
650 6 |a Tuberculose multirésistante  |v Congrès. 
650 6 |a Tuberculose  |v Congrès. 
650 6 |a Résistance aux médicaments  |v Congrès. 
650 6 |a Antituberculeux  |v Congrès. 
650 6 |a Tuberculose multirésistante. 
650 6 |a Antituberculeux. 
650 7 |a MEDICAL  |x Oncology.  |2 bisacsh 
650 7 |a Antitubercular agents  |2 fast 
650 7 |a Drug resistance  |2 fast 
650 7 |a Multidrug-resistant tuberculosis  |2 fast 
650 7 |a Tuberculosis  |2 fast 
655 2 |a Congress 
655 7 |a proceedings (reports)  |2 aat 
655 7 |a Conference papers and proceedings  |2 fast 
655 7 |a Conference papers and proceedings.  |2 lcgft 
655 7 |a Actes de congrès.  |2 rvmgf 
700 1 |a Giffin, Robert B. 
700 1 |a Robinson, Sally. 
710 2 |a Institute of Medicine (U.S.).  |b Forum on Drug Discovery, Development, and Translation. 
758 |i has work:  |a Addressing the threat of drug-resistant tuberculosis (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCFV7KG4rhJqWDDyQYRFRDm  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t Addressing the threat of drug-resistant tuberculosis.  |d Washington, D.C. : National Academies Press, 2009  |z 9780309130448  |w (OCoLC)443095144 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3378570  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36615268 
938 |a Internet Archive  |b INAR  |n addressingthreat0000unse 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36558427 
938 |a Coutts Information Services  |b COUT  |n 12122864 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL3378570 
938 |a ebrary  |b EBRY  |n ebr10364020 
938 |a EBSCOhost  |b EBSC  |n 308620 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n 245484 
938 |a YBP Library Services  |b YANK  |n 3289034 
994 |a 92  |b IZTAP